Department of Pharmacology, University College London, Hampstead Campus, Rowland Hill Street, London NW3 2PF, UK.
Eur J Pharmacol. 2012 May 5;682(1-3):142-52. doi: 10.1016/j.ejphar.2012.02.010. Epub 2012 Feb 21.
Central and peripheral 5-hydroxytryptamine (5-HT) receptors play a critical role in the regulation of micturition. Bolus doses of 5-HT(2A/2C) receptor agonists have been shown to activate the external urethral sphincter (EUS) and to inhibit micturition. This study was designed to determine the contribution of these two 5-HT receptor subtypes to activation of the EUS and inhibition of micturition utilising pharmacokinetic knowledge to better control drug exposure. Recordings of urethral and bladder pressure, EUS-Electromyogram (EMG), the micturition reflex induced by bladder filling, blood pressure and heart rate were made in anaesthetized female rats. The effects of intravenous (i.v.) infusions of the 5-HT(2) receptor agonist (2S)-1-(6-chloro-5-fluoroindol-1-yl)propan-2-amine fumarate (Ro 60-0175) in the absence or presence of the selective 5-HT(2C) receptor antagonist 6-chloro-5-methyl-N-[6-(2-methylpyridin-3-yl)oxypyridin-3-yl]-2,3-dihydroindole-1-carboxamide dihydrochloride (SB 242084) or 5-HT(2A) receptor antagonist (R)-(2,3-dimethoxyphenyl)-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]methanol (MDL-100,907) were studied on these variables. Continuous infusion of increasing concentrations of Ro 60-0175 only evoked EUS-EMG activity at the highest concentration, which was blocked by co-infusion of MDL-100,907 but not SB 242084. Urethral pressure was unaffected by any drug infusion. Ro 60-0175 at the lowest concentration inhibited the micturition reflex but as the concentration increased this was reversed to facilitation. SB 242084 blocked the inhibition while MDL-100,907 blocked the excitation. Activation of 5-HT(2A) not 5-HT(2C) receptors evoked EUS-EMG activity. In conclusion, 5-HT(2A) receptor activation facilitated the micturition reflex and evoked EUS-EMG while 5-HT(2C) receptor activation only inhibited the micturition reflex.
中枢和外周 5-羟色胺(5-HT)受体在调节排尿中起着关键作用。已经表明,5-HT(2A/2C)受体激动剂的推注剂量可激活尿道外括约肌(EUS)并抑制排尿。本研究旨在利用药代动力学知识更好地控制药物暴露,确定这两种 5-HT 受体亚型对 EUS 激活和排尿抑制的贡献。在麻醉雌性大鼠中记录尿道和膀胱压力、EUS-肌电图(EMG)、膀胱充盈诱导的排尿反射、血压和心率。在不存在或存在选择性 5-HT(2C)受体拮抗剂 6-氯-5-甲基-N-[6-(2-甲基吡啶-3-基)氧吡啶-3-基]-2,3-二氢吲哚-1-羧酸二盐酸盐(SB 242084)或 5-HT(2A)受体拮抗剂(R)-[(2,3-二甲氧基苯基)-[1-[2-(4-氟苯基)乙基]哌啶-4-基]甲醇(MDL-100,907)的情况下,研究了静脉内(i.v.)输注 5-HT(2)受体激动剂(2S)-1-(6-氯-5-氟吲哚-1-基)-2-丙胺富马酸盐(Ro 60-0175)的作用。只有在最高浓度时,连续输注递增浓度的 Ro 60-0175 仅引起 EUS-EMG 活动,该活动被 MDL-100,907 共输注阻断,但不受 SB 242084 影响。尿道压力不受任何药物输注的影响。Ro 60-0175 在最低浓度抑制排尿反射,但随着浓度的增加,这种抑制被逆转为促进。SB 242084 阻断抑制,而 MDL-100,907 阻断兴奋。激活 5-HT(2A)而非 5-HT(2C)受体引起 EUS-EMG 活动。总之,5-HT(2A)受体的激活促进了排尿反射并引起了 EUS-EMG,而 5-HT(2C)受体的激活仅抑制了排尿反射。